ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $510,732 | +10.5% | 12,592 | -9.8% | 0.01% | 0.0% |
| Q3 2022 | $462,000 | -9.2% | 13,964 | -3.4% | 0.01% | -11.1% |
| Q2 2022 | $509,000 | -25.5% | 14,449 | -2.7% | 0.01% | -10.0% |
| Q1 2022 | $683,000 | -31.1% | 14,845 | -0.8% | 0.01% | -23.1% |
| Q4 2021 | $992,000 | +2.1% | 14,960 | -3.9% | 0.01% | -7.1% |
| Q3 2021 | $972,000 | -27.8% | 15,563 | -4.3% | 0.01% | -26.3% |
| Q2 2021 | $1,346,000 | +22.6% | 16,256 | -1.9% | 0.02% | +11.8% |
| Q1 2021 | $1,098,000 | -16.1% | 16,564 | -2.8% | 0.02% | -22.7% |
| Q4 2020 | $1,308,000 | +74.9% | 17,048 | -1.8% | 0.02% | +46.7% |
| Q3 2020 | $748,000 | -0.9% | 17,362 | -0.6% | 0.02% | -6.2% |
| Q2 2020 | $755,000 | +52.2% | 17,471 | +1.2% | 0.02% | +33.3% |
| Q1 2020 | $496,000 | -55.6% | 17,256 | -1.9% | 0.01% | -50.0% |
| Q4 2019 | $1,116,000 | +120.1% | 17,599 | -2.1% | 0.02% | +118.2% |
| Q3 2019 | $507,000 | +4.3% | 17,981 | -1.9% | 0.01% | 0.0% |
| Q2 2019 | $486,000 | +23.0% | 18,323 | -14.7% | 0.01% | +22.2% |
| Q1 2019 | $395,000 | +18.3% | 21,481 | -20.1% | 0.01% | +12.5% |
| Q4 2018 | $334,000 | – | 26,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |